Company research
Latest IS Pharma comment
IS Pharma
January 26 2009
Featured in the champion review:
A second batch of ‘AIM for IHT’ stock considerations from 2008 with H (H&T Group) to L (James Latham). Quite by accident another pawnbroker leads the way!
Login or register to download.
More on IS Pharma
| Type | Summary | |
|---|---|---|
| Blog Published: 06/10/2010 |
IS Pharma plc – placing at a premium gives confidence and we get a dividend as well | |
| Blog Published: 02/06/2010 |
IS Pharma plc (AIM: ISPH), results marginally miss estimates but no big deal in the grand scheme | |
| Blog Published: 30/04/2010 |
IS Pharma (LON:ISPH) | |
| Blog Published: 04/03/2010 |
IS Pharma (LON:ISPH) snaps up the rights to Episil | |
| Blog Published: 23/11/2009 |
IS Pharma : Variquel® approval and management continues to shine | |
| Champion Review Published: 26/01/2009 |
A second batch of ‘AIM for IHT’ stock considerations from 2008 with H (H&T Group) to L (James Latham). Quite by accident another pawnbroker leads the way! | Login or register to download. |
| Champion Review Published: 12/09/2008 |
TOROTRAK The technology with this one may be great, but without any idea what the earnings potential is there is no way to gauge what premium (if any) the shares should be on to the net cash in the balance sheet – can anyone help the Champion? | Login or register to download. |
| Champion Review Published: 13/06/2008 |
Poor old Chamberlin! Its foundry has been around since 1890 and now it is subject to a ‘nuisance claim’ from a new housing development. No wonder British industry has a tough time | Login or register to download. |
- Worth having a look at for Inheritance Tax planning portfolios
- Energy Equipment & Services theme companies
